NURECA

₹386.65 -21.6 (-5.29%)

22 Jan, 2025 12:15

SIP TrendupStart SIP in NURECA

Start SIP

Performance

  • Low
  • ₹382
  • High
  • ₹414
  • 52 Week Low
  • ₹240
  • 52 Week High
  • ₹448
  • Open Price₹410
  • Previous Close₹408
  • Volume57,425

Investment Returns

  • Over 1 Month + 36.92%
  • Over 3 Month + 31.25%
  • Over 6 Month + 44.22%
  • Over 1 Year -2.44%
SIP Lightning

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -138
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 387
  • P/B Ratio
  • 2
  • Average True Range
  • 32.06
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 21.97
  • RSI
  • 66.18
  • MFI
  • 79.99

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹386.65
-21.6 (-5.29%)
pointer
  • stock-down_img
  • Bearish Moving Average 2
  • stock-up_img
  • Bullish Moving Average 14
  • 20 Day
  • ₹350.00
  • 50 Day
  • ₹320.30
  • 100 Day
  • ₹309.60
  • 200 Day
  • ₹312.33

Resistance and Support

415.5 Pivot Speed
  • R3 459.50
  • R2 447.25
  • R1 427.75
  • S1 396.00
  • S2 383.75
  • S3 364.25

What's your outlook on Nureca?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 90.80 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 37% and 41% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 19 indicates it belongs to a strong industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results
2024-08-05 Quarterly Results
2024-05-15 Audited Results
2024-02-07 Quarterly Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View More

Nureca F&O

Nureca Shareholding Pattern

64.06%
0.36%
33.27%
2.31%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹386 As on 22 January, 2025 | 12:01

The Market Cap of Nureca is ₹386.7 Cr As on 22 January, 2025 | 12:01

The P/E ratio of Nureca is -138 As on 22 January, 2025 | 12:01

The PB ratio of Nureca is 2 As on 22 January, 2025 | 12:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23